Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AdaptHealthAHCO -2.92%64 Days Payable is 58.92 as of Jun. 2026, which is 64% above its 10-year median of 35.92. GuruFocus rates AHCO with a GF Score™ of 64/100 and a GF Value™ of $10.50 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, AdaptHealth ranks worse than 65.49% on this metric.
The historical data trend for AdaptHealth's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, AdaptHealth's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AdaptHealth Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AdaptHealth's Days Payable distribution charts can be found below:
* The bar in red indicates where AdaptHealth's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
AdaptHealth's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AdaptHealth (AHCO) has a Days Payable of 58.92 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AdaptHealth and its competitors. This is 64% above median its historical median of 35.92. Over the past decade, AdaptHealth's Days Payable has ranged from 30.75 to 54.89. According to the industry distribution chart, AdaptHealth ranks #520 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 65.5%.
Is AdaptHealth's Days Payable too high?
AdaptHealth's current Days Payable of 58.92 is 64% above median its 10-year median of 35.92. Over the past 10 years, this metric has ranged from a low of 30.75 to a high of 54.89. The Medical Devices & Instruments industry median Days Payable is 68.62. AdaptHealth's value of 58.92 is 14.1% below this industry median. Based on the distribution chart, AdaptHealth ranks #520 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AdaptHealth has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AdaptHealth's Days Payable compare to INSP and IART?
According to the Medical Devices & Instruments industry distribution chart, AdaptHealth ranks #520 out of 794 companies for Days Payable. This places AdaptHealth in the lower half of its industry. The industry median Days Payable is 68.62. AdaptHealth's value of 58.92 is 14.1% below this benchmark. Historically, AdaptHealth's own Days Payable has ranged from 30.75 to 54.89 over the past decade. While the company's 10-year median is 35.92 vs. the industry median of 68.62, AdaptHealth has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.62, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AdaptHealth's current Days Payable of 58.92 is 14.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on AdaptHealth and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AdaptHealth's current Days Payable is 58.92, which is 64% above median its own 10-year median of 35.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AdaptHealth stock overvalued right now?
Based on GuruFocus' analysis, AdaptHealth (AHCO) is currently considered Possible Value Trap. The stock's GF Value™ is $10.50, compared to a current price of $5.66 — trading 46.1% below its estimated fair value. The current Days Payable is 58.92, which is 64% above median its 10-year median of 35.92 and 14.1% below the Medical Devices & Instruments industry median of 68.62. AdaptHealth's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For AdaptHealth (AHCO), the current Days Payable is 58.92 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AdaptHealth (AHCO) Overvalued in 2026?
Based on GuruFocus' analysis, AdaptHealth stock appears to be undervalued.
The current stock price of $5.66 is trading 46.1% below its estimated GF Value™ of $10.50.
GuruFocus considers AdaptHealth to be Possible Value Trap.
Key valuation signals for AHCO:
Days Payable: 58.92 (64% above median its 10-year median of 35.92)
GF Value™: $10.50 vs. price of $5.66 (46.1% below fair value)
Industry Position: 14.1% below the Medical Devices & Instruments median (#520 of 794)
No single metric tells the full story. See the AHCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
64GF Score
Get the complete analysis for AHCO
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AHCO has been successfully added to your 
